. Author manuscript; available in PMC: 2014 Dec 1.

Published in final edited form as: Prog Transplant. 2013 Dec;23(4):374–382. doi: 10.7182/pit2013996

Table 3.

Organ count and results of metabolic cart, breath test, and laboratory studies: treatment group vs control group

		Fed^a		Fasted

Variable	Time point^b	No. of patients	Value	No. of patients	Value	P
Organ count, No. (%)

Organs procured	——	18	4.4 (2.0)	18	4.6 (1.5)	.78
Organs transplanted	——	18	4.1 (2.1)	18	3.5 (1.8)	.36

Metabolic cart results, mean (SD)

Resting energy expenditure (REE), kcal/d	T1	16	1773 (778.8)	17	1954 (691.9)	.47^c
	T2	18	2098 (920.0)	17	1974 (666.1)	.65

REE predicted, kcal/d	T1	16	1727 (268.3)	17	1659 (369.3)	.55
	T2	18	1698 (267.1)	17	1659 (369.3)	.72

REE, kcal/d (values available for both tests)	T1	16	1773 (778.8)	17	1954 (691.9)	.47^c
	T2	16	2109 (978.7)	17	1974 (666.1)	.64

REE predicted, kcal/d (values available for both tests)	T1	16	1727 (268.3)	17	1659 (369.3)	.55
	T2	16	1727 (268.3)	17	1659 (369.3)	.55

Timed urine urea nitrogen, mg/dL	T1	17	297.9 (254.7)	17	444.3 (459.8)	.35^c
	T2	17	500.9 (468.2)	18	323.1 (296.2)	.16^c

Body temperature, °C	T1	16	36.6 (1.5)	18	37.0 (1.3)	.39
	T2	16	37.1 (1.3)	15	36.8 (0.9)	.44

Breath test results, mean (SD)

Positive, assimilated	T1	18	6 (33)	18	4 (22)	.46
	T2	18	5 (28)	18	6 (33)	.72

Laboratory study results, mean (SD)

Serum albumin, g/dL	T1	17	3.1 (0.7)	18	2.9 (0.6)	.50
	T2	16	2.7 (0.7)	14	2.7 (0.4)	.85
	OR^d	18	2.6 (0.6)	18	2.6 (0.5)	.88

Prealbumin, mg/dL	T1	18	16.4 (5.3)	18	16.3 (6.5)	.95
	T2	18	14.0 (3.5)	18	14.2 (5.2)	.87

C-reactive protein, mg/L	T1	18	10.8 (9.3)	18	14.2 (10.3)	.31
	T2	18	17.0 (8.0)	18	17.7 (9.7)	.84
	OR^d	18	17.3 (8.1)	18	18.3 (8.5)	.72

Creatinine, mg/dL	T1	18	2.1 (2.9)	17	1.3 (0.5)	.87^c
	T2	16	1.4 (0.7)	16	1.2 (0.7)	.52^c
	OR^d	18	2.1 (3.1)	18	1.4 (0.6)	.79^c

Alanine aminotransferase, U/L	T1	18	54.8 (82.9)	17	31.9 (12.8)	.62^c
	T2	16	67.7 (103.3)	15	37.6 (29.4)	.77^c
	OR^d	18	79.0 (152.2)	18	36.4 (27.5)	.60^c

Blood glucose, mg/dL	T1	11	160.9 (67.5)	16	133.4 (40.5)	.20
	T2	14	176.5 (63.3)	14	170.3 (38.9)	.76
	OR^d	18	170.9 (58.5)	18	147.3 (40.8)	.17

Serum urea nitrogen, mg/dL
	T1	18	21.5 (28.4)	17	14.4 (8.4)	.99^c
	T2	16	16.3 (14.9)	16	13.7 (10.7)	.35^c
	ORc	18	23.8 (27.5)	18	17.4 (12.6)	.57^c

Interleukin 6, pg/mL	T1	18	2162 (3023)	18	1473 (1701)	.74^c
	T2	18	264.9 (285.6)	18	565.5 (1010)	.48^c
	OR^d	18	283.1 (581.9)	18	522.1 (1022)	.35^c

Tumor necrosis factor–α, pg/mL
	T1	18	22.1 (21.0)	18	20.5 (16.1)	.84^c
	T2	18	12.6 (9.6)	18	12.6 (9.8)	.61^c
	OR^d	18	12.4 (9.3)	18	13.0 (10.4)	.80^c

SI conversion factors: To convert albumin and prealbumin to g/L, multiply by 10; to convert C-reactive protein to nmol/L, multiply by 9.524; to convert creatinine to umol/L, multiply by 88.4; to convert alanine aminotransferase to ukat/L, multiply by 0.0167; to convert blood glucose to mmol/L, multiply by 0.0555; to convert serum urea nitrogen to mmol/L, multiply by 0.357.

Patient (HN-06) was randomized to the group with nutritional supplement but failed to receive the intervention.

T1 is before receiving the feeding intervention; T2 is 12 ± 2 hours after baseline; OR is just before transfer to the operating room.

Wilcoxon rank sum test for variables not normally distributed. Fisher’s exact test for variables with small expected cell number. Others: t test for continuous variables and χ² test for categorical variables. No significant results were found for any variables.

For the patient without values at OR, the last available values were used.